CSIMarket
 


Renalytix Plc  (RNLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Renalytix Plc's Quick Ratio for Trailing Twelve Months Period

RNLX's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

RNLX Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Jun 30 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
Y / Y Current Liabilities Growth 28.85 % 37.02 % 72.21 % 72.21 % 72.21 %
Y / Y Cash & cash equivalent Growth -66.39 % -40.29 % -36.54 % -36.54 % -36.54 %
Quick Ratio for Trailing Twelve Months Period 2.21 2.89 3.51 4.49 5.72
Total Ranking # 913 # 836 # # #
Seq. Current Liabilities Growth -5.97 % 37.02 % 0 % 0 % 0 %
Seq. Cash & cash equivalent Growth -43.72 % -40.29 % 0 % 0 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to decrease in Current Liabilities in the I. Quarter to $15 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 2.21 below Renalytix Plc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 26 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Renalytix Plc. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about RNLX
Quick Ratio RNLX in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 27
Sector # 708
S&P 500 # 1465


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.22 5.16 2.21
(Jun 30 2021)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Laboratories Industry Quick Ratio for Trailing Twelve Months Period
Omniab Inc   6.02 
Exagen Inc   5.46 
Science 37 Holdings Inc   5.33 
Personalis Inc   5.20 
Guardant Health Inc   5.09 
Ispecimen inc   4.81 
Bioaffinity Technologies Inc   4.68 
Absci Corp  4.39 
Caredx Inc   4.06 
Zymergen Inc.  3.81 
Veracyte inc   3.60 
Butterfly Network inc   3.47 
Nano x Imaging Ltd  3.10 
Invitae Corporation  3.04 
Incyte Corporation  3.04 
Burning Rock Biotech Limited  2.43 
Fulgent Genetics Inc   2.24 
Renalytix Plc  2.21 
Vyant Bio Inc   2.20 
Enzo Biochem Inc  2.07 
Natera inc   1.83 
Biocept Inc   1.80 
Exact Sciences Corporation  1.70 
American Shared Hospital Services  1.70 
Bionexus Gene Lab Corp   0.94 
Centogene N v   0.90 
Radnet Inc   0.79 
Hologic Inc  0.78 
Opgen inc   0.78 
National Research Corporation  0.63 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com